Actos Side Effects Include Bladder Cancer

Click Here To Download Our Actos Bladder Cancer Info Kit!

Large Study On Actos Side Effects Results In First Safety Alert

In September of 2010 the FDA issued the following statement “FDA notified healthcare professionals and patients that the Agency is reviewing data from an ongoing, ten-year epidemiological study designed to evaluate whether Actos (pioglitazone) is associated with an increased risk of bladder cancer. Findings from studies in animals and humans suggest this is a potential safety risk that needs further study. At this time, FDA has not concluded that Actos increases the risk of bladder cancer. Its review is ongoing, and the Agency will update the public when it has additional information.” The FDA’s recommendation to healthcare providers at this point was to continue to follow the recommendations in the drug label when prescribing Actos. It was not until close to a year later that a change to the warning label was made.

FDA Issues A Second Update On Actos Bladder Cancer

On June 15, 2011 the FDA issued an update on it’s investigation of the association between Actos and bladder cancer. This time the FDA issued a warning stating “(u)se of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines will also be revised to include information on the risk of bladder cancer.” They also recommended that healthcare professionals should not use pioglitazone in patients with active bladder cancer, and use pioglitazone with caution in patients with a prior history of bladder cancer. The benefits of blood sugar control with pioglitazone should be weighed against the unknown risks for cancer recurrence.

FDA Finally Adds Actos Bladder Cancer To Label

The FDA issued another warning in August 2011 regarding Actos side effects. The FDA updated the labeling of this medication, to include safety information that the use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer.

Needless to say with all these updates and warning information, if you or your loved one have been prescribed Actos, please speak to your physician regarding the potential risk of bladder cancer due to taking this medication.



, , , , ,

No comments yet.

Leave a Reply

GET HELP NOW!

Your Name (required)

Your Email (required)

Your Phone Number (required)

Tell Us How We Can Help

Latest Drug Injury News

A Fake Cancer Drug Infuriates Real Cancer Patients

Cancer patients are furious that a counterfeit version of the drug Avastin has landed in U.S. clinics.  But, who wouldn’t be when your life is on the line?  Definitely can’t blame them one bit! The counterfeit version was just discovered at U.S. health care facilities, prompting the maker of the cancer drug to warn doctors [...]

Another Dietary Supplement, RegenArouse, Recalled By FDA

Seems like lately we’ve written a lot about dietary supplements.  Apparently the FDA is cracking down on dietary supplements that contain ingredients that have not been approved by the FDA.  Just last week we told you about the recall that Healthy People Co made due to unlisted ingredients, and now, RegenArouse is the latest to [...]

New Study Questions Controversial Lung Cancer Treatment

A recent study is questioning a controversial radiation treatment for lung cancer, that may not benefit the life expectancy of a cancer patient. The treatment, Postoperative radiotherapy (PORT), according to U.S. researchers, may not help increase the life span of elderly patients, said Reuters Health. PORT is believed to help minimize the likelihood of a [...]

New FDA Recommendations To Prevent Another Heparin Contamination

Four years after US drug-maker Baxter International’s blood thinner heparin was contaminated in China, causing dozens of deaths, lawmakers urged the FDA to prevent another heparin scare, during a recent hearing at the U.S. House of Representatives. Therefore, US regulators issued draft guidelines to ensure the safe production of the blood-clot prevention. “We’re making sure [...]

Heartburn Meds Linked To A Diarrhea That Just Won’t Go Away

Heartburn is a frustrating thing to have to deal with, but chronic heartburn is just down right aggravating.  One way to treat it is by taking a medication called Proton Pump Inhibitors (PPIs). PPI’s are available by a prescription, and over the counter.  Prescription PPIs are used to treat conditions such as gastroesophageal reflux disease [...]

Latest Medical Device Injury News

Two California Surgery Centers Halt Lab Band Surgeries At Least Temporarily

Just a few weeks ago we reported the controversy around 1-800-GET-THIN promotion in Southern California.  There are several reports of patients dying, as well as possible fraudulent activity. Now, a pair of southern California clinics that advertise via the 1-800-GET-THIN promotion have agreed to stop performing Lap-Band gastric band weight-loss procedure. “Unfortunately, recent allegations question [...]

Latest Info On Metal On Metal Hip Implants

Doctors have known for several years that some hip devices, in which both the ball and cup are made of metal, were failing at faster rates than other hip implants.  Now, new research is confirming this information and claiming that the problem can cause trouble for many years to come, even after removal. “This is [...]

Medical Device Industry And FDA Reach Fee Agreement After Negotiations Took Place

Just a few weeks ago, we reported that the FDA had missed a January 15 deadline to submit a new agreement on medical device fees to U.S. lawmakers.  Well, apparently negotiations are over.  The FDA and medical device makers have reached an agreement on the fees. Device makers will double product review fees paid to [...]

Lap-Band Surgery Centers In Hot Water With Death Toll Rising & Possible Fraudulent Activity

Just last week we reported that a group of Democratic lawmakers were calling on the Republicans who control the House Energy and Commerce Committee for a safety review concerning 2 controversial medical devices.  Now it just so happens that one of those devices, The Lap-Band, is again in the news, and the topic of this [...]

Johnson & Johnson Suffering From Manufacturing Issues and Recalls

The drug & medical device giant Johnson & Johnson seems to be a name that is coming up a lot lately; from the controversial chemicals found in baby products to the major artificial hip recall surrounding DuPuy Orthopaedic’s, they continually seem to be on the radar. Now, in their just released last quarter financial statement [...]